Switzerland· 50497001
Livostin Nasenspray, Suspension
A levocabastine product, registered in Switzerland by JNTL Consumer Health II (Switzerland) GmbH and dispensed under Swissmedic category D. The same ATC class is registered in 10 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Levocabastine is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AC02 (levocabastine), each read from that country’s own register.
- This record: Switzerland
- 6 of them publish a price we can compare per daily dose
Levocabastine · ATC R01AC02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- JNTL Consumer Health II (Switzerland) GmbH
- Country
- Switzerland (CH)
- ATC code
- R01AC02
- ATC class
- Levocabastine
- Defined daily dose
- 0.6 mg, N
- Swissmedic category
- D
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R01AC02
Levocabastine, as other registers publish it.
- DenmarkBenalivMcNeil Denmark ApS
- GermanyLevocabastinDermapharm Ag
- GermanyLevocamedDermapharm Ag
- NetherlandsLivocab 0,5 mg/ml neusspray, suspensieKenvue Netherlands B.V.
- GermanyLivocab Direkt NasensprayKenvue Germany Gmbh
- FinlandLivostinOrion Corporation Orion Pharma
- FinlandLivostinParanova Oy
- IcelandLivostinMcNeil Sweden AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4b5bc4d-2e30-4afa-a28d-e7375440a2d2 GET /v1/drugs/e4b5bc4d-2e30-4afa-a28d-e7375440a2d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about levocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.